A Study of BPI-1178 in Patients With Advanced Solid Tumor and HR+/HER2- Breast Cancer

Conditions:   Advanced Solid Tumor;   Breast Neoplasms Interventions:   Drug: BPI-1178;   Drug: Fulvestrant;   Drug: Letrozole Sponsor:   Beta Pharma (Suzhou) Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials